Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_assertion description "[Recent research suggests that women who develop breast cancer between the ages of 30-34 may have specific tumour characteristics: Those with high grade, oestrogen receptor negative, human epidermal growth factor receptor 2 (HER-2) negative tumours have between a 10% and 27% chance of being a BRCA1 gene carrier.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_assertion evidence source_evidence_literature NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_assertion SIO_000772 15952973 NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_assertion wasDerivedFrom befree-2016 NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_assertion wasGeneratedBy ECO_0000203 NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.
- befree-2016 importedOn "2016-02-19" NP499217.RAREo4yY-bTX7ZbJK0nrIYMghud1rPuU-0tDSVDMcO0l0130_provenance.